Evidence map›Paper›PMID 31704779›Full record

ReviewJournal of medical genetics2020

Cornelia de Lange syndrome: from molecular diagnosis to therapeutic approach.

Patrizia Sarogni, Maria M Pallotta, Antonio Musio

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of medical genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Co-Occurrence ofInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Case Report: A novel intronic variant ofFrontiers in genetics · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. A novelFrontiers in genetics · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Cornelia de Lange syndrome and cancer: An open question.American journal of medical genetics. Part A · 2023
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Patrizia SarogniIstituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Pisa, Italy.
Maria M PallottaIstituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Pisa, Italy.
Antonio MusioIstituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Pisa, Italy antonio.musio@irgb.cnr.it.ORCID 0000-0001-7701-6543
Institute of Genetic and Biomedical Research · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cornelia de Lange syndrome (CdLS) is a severe genetic disorder characterised by multisystemic malformations. CdLS is due to pathogenetic variants in

Indexed as

Abnormalities, MultipleCell Cycle ProteinsChondroitin Sulfate ProteoglycansChromatidsChromosomal Proteins, Non-HistoneCohesinsDe Lange SyndromeDNA-Binding ProteinsHistone DeacetylasesHumansMutationRepressor ProteinsStructural Maintenance of Chromosome Protein 1Cell Cycle ProteinsChondroitin Sulfate ProteoglycansChromosomal Proteins, Non-HistoneCohesinsDNA-Binding ProteinsHDAC8 protein, humanHistone DeacetylasesNIPBL protein, humanRAD21 protein, humanRepressor ProteinsSMC3 protein, humanStructural Maintenance of Chromosome Protein 1cohesinCornelia de Lange syndromegene dysregulationgenome instabilitytherapeutic approaches

Identifiers

PMID31704779
PMCPMC7231464
OpenAlexW2986237382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.